Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruffie

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancerT Le Chevalier, A Monnier, J Y Douillard, et al.
Anticancer Research|January 1, 1994
Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue françaiseD Moro, P Jacoulet, E Quoix, et al.
Bulletin Du Cancer|January 1, 1992
[Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial]E Nasr, B Pellae-Cosset, R Arriagada, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaT Le Chevalier, R Arriagada, E Quoix, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialistsR Arriagada, T Le Chevalier, E Quoix, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Journal of the National Cancer Institute|March 20, 1991
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patientsT Le Chevalier, R Arriagada, E Quoix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1989
Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: evaluation of a grading system of lung fibrosisR Arriagada, J C de Guevara, H Mouriesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1985
Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited diseaseR Arriagada, T Le Chevalier, P Baldeyrou, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancerT Le Chevalier, A Monnier, J Y Douillard, et al.
Anticancer Research|January 1, 1994
Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue françaiseD Moro, P Jacoulet, E Quoix, et al.
Bulletin Du Cancer|January 1, 1992
[Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial]E Nasr, B Pellae-Cosset, R Arriagada, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaT Le Chevalier, R Arriagada, E Quoix, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialistsR Arriagada, T Le Chevalier, E Quoix, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Journal of the National Cancer Institute|March 20, 1991
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patientsT Le Chevalier, R Arriagada, E Quoix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1989
Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: evaluation of a grading system of lung fibrosisR Arriagada, J C de Guevara, H Mouriesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1985
Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited diseaseR Arriagada, T Le Chevalier, P Baldeyrou, et al.
Pageof 4